4Series on the Lancet Oncology Commission on Global Cancer Surgery: Introduction-Intent and Content.PubMed译柳叶刀肿瘤学委员会全球癌症手术系列：引言——意图和内容。
Chandrakanth Are, Makayla Schissel, Lynette M Smith, et al.
Ann Surg Oncol. 2024 Aug;31(8):4868-4872. doi: 10.1245/s10434-024-15554-9. Epub 2024 Jun 3.
5Series on The Lancet Oncology Commission on Global Cancer Surgery-Action 1: Clinical Care and Access to Cancer Surgery.PubMed译《柳叶刀·肿瘤学》全球癌症手术委员会系列——行动1：癌症手术的临床护理与可及性
Ann Surg Oncol. 2025 Jan;32(1):42-46. doi: 10.1245/s10434-024-16167-y. Epub 2024 Nov 7.
6Radiotherapy for breast cancer: The predictable consequences of an unmet need.PubMed译乳腺癌放疗：需求未满足的可预测后果。
81991 national survey of carcinoma of the breast by the Commission on Cancer.PubMed译1991年癌症委员会进行的全国乳腺癌调查。
et al.
J Am Coll Surg. 1994 Mar;178(3):213-9.
9Validation of probable COPD as proposed by the Lancet Commission at a smoking cessation clinic.PubMed译《柳叶刀》委员会提议的可能的慢性阻塞性肺疾病（COPD）在戒烟诊所的验证。
et al.
Respir Med. 2025 Apr;239:108004. doi: 10.1016/j.rmed.2025.108004. Epub 2025 Feb 18.
10Transforming Breast Cancer Together: European elections manifesto 2019 seizing the opportunities for breast cancer patients.PubMed译共同改变乳腺癌：2019 年欧洲选举宣言——为乳腺癌患者抓住机遇
Fatima Cardoso, Cristian-Silviu Bușoi, Ivana Cattaneo, et al.
1Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.PubMed译基线止血生物标志物评估可识别出化疗期间发生静脉血栓栓塞高风险的乳腺癌患者。
et al.
Cancers (Basel). 2025 Aug 20;17(16):2712. doi: 10.3390/cancers17162712.
2A machine learning approach to predict self-efficacy in breast cancer survivors.PubMed译一种预测乳腺癌幸存者自我效能的机器学习方法。
et al.
BMC Med Inform Decis Mak. 2025 Aug 19;25(1):313. doi: 10.1186/s12911-025-03155-9.
3Integrating single-cell regulatory atlas and multi-omics data for differential treatment response and multimodal predictive modeling in CDK 4/6 inhibitor-treated breast cancer.PubMed译整合单细胞调控图谱和多组学数据用于CDK 4/6抑制剂治疗的乳腺癌中的差异治疗反应和多模态预测建模
et al.
Front Oncol. 2025 Jul 17;15:1585574. doi: 10.3389/fonc.2025.1585574. eCollection 2025.
4CLGB-Net: fusion network for identifying local and global information of lesions in digital mammography images.PubMed译CLGB-Net：用于识别数字乳腺X线摄影图像中病变局部和全局信息的融合网络。
et al.
Front Oncol. 2025 Jul 17;15:1600057. doi: 10.3389/fonc.2025.1600057. eCollection 2025.
5The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study.PubMed译主流基因检测途径和社会经济因素对乳腺癌患者接受种系基因检测的影响：全国性GENE-SMART研究结果
et al.
Breast Cancer Res. 2025 Jul 14;27(1):129. doi: 10.1186/s13058-025-02081-y.
6Advancing equitable access to innovation in breast cancer.PubMed译推进乳腺癌创新的公平可及性。
et al.
NPJ Breast Cancer. 2025 Jul 10;11(1):71. doi: 10.1038/s41523-025-00768-1.
7Contemporary Considerations for Breast Cancer Risk and Screening in Transgender, Nonbinary, and Gender-Diverse Populations.PubMed译变性者、非二元性别者及性别多样化人群乳腺癌风险与筛查的当代考量
et al.
Curr Breast Cancer Rep. 2025;17. doi: 10.1007/s12609-025-00573-6. Epub 2025 Feb 13.
8Understanding global variation in breast cancer mortality.PubMed译了解乳腺癌死亡率的全球差异。
9Awareness of Breast Cancer Among Male and Female High School Students in Southern Ghana.PubMed译加纳南部男女高中生对乳腺癌的认知情况
et al.
Int J Breast Cancer. 2025 Jun 23;2025:5710341. doi: 10.1155/ijbc/5710341. eCollection 2025.
10Global burden of breast cancer and application of patient-reported outcomes in clinical trials: a systematic analysis based on the global burden of disease study 2021 and WHO international clinical trial register database.PubMed译乳腺癌的全球负担及患者报告结局在临床试验中的应用：基于2021年全球疾病负担研究和世界卫生组织国际临床试验注册数据库的系统分析
et al.
Front Oncol. 2025 Jun 12;15:1557080. doi: 10.3389/fonc.2025.1557080. eCollection 2025.
